Shemyakin-Ovchinnikov Institute Of Bioorganic Chemistry Russian Academy Of Sciences;Alexey Vya;PJSC Pharmsynthez;Alexey Vyacheslavovich STEPANOV;OPKO PHARMACEUTICALS LLC;THE SCRIPPS RESEARCH INSTITUTE
Described are methods for providing personalized medicine for the treatment of В cell malignancies including lymphoma. The methods make use of Chimeric Antigen Receptor (CAR) technology.